Cremer, S., Pilgram, L., Berkowitsch, A., Stecher, M., Rieg, S., Shumliakivska, M., . . . group, L. s. (2021). Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Cremer, Sebastian, et al. Angiotensin II Receptor Blocker Intake Associates with Reduced Markers of Inflammatory Activation and Decreased Mortality in Patients with Cardiovascular Comorbidities and COVID-19 Disease. Public Library of Science (PLoS), 2021.
Cita MLA (8a ed.)Cremer, Sebastian, et al. Angiotensin II Receptor Blocker Intake Associates with Reduced Markers of Inflammatory Activation and Decreased Mortality in Patients with Cardiovascular Comorbidities and COVID-19 Disease. Public Library of Science (PLoS), 2021.